前言 高血压在被调查的大约1％的美国空军飞行人员中成为一个航空医学因素。自从60年代初以来,可以放宽标准的治疗限于利尿剂。Lisinopril是一种血管紧张素转换酶抑制剂,于1987年被美国联邦食品与药物管理局批准用于治疗高血压。随机双盲研究显示它治疗高血压是安全和有效的,仅有很小的副作用。阿姆斯特朗研究所的临床科学部正在研究Lsinopril,以确定该药用于患高血压的美国空军飞行人员的 Introduction Hypertension became an aeromedical factor among approximately 1% of U.S. Air Force pilots surveyed. Since the early 1960s, standard treatments can be relaxed for diuretics. Lisinopril, an angiotensin-converting enzyme inhibitor, was approved by the U.S. Food and Drug Administration in 1987 for the treatment of hypertension. Randomized double-blind studies have shown that it is safe and effective in the treatment of hypertension, with only minor side effects. The Clinical Science Division of the Armstrong Institute is investigating Lsinopril to determine the drug’s use for high-pressure U.S. Air Force pilots